Management of Central Nervous System Infections, Vientiane, Laos, 2003-2011.

Asia Cryptococcus Japanese encephalitis virus Lao Laos Leptospira Orientia tsutsugamushi Rickettsia WHO encephalitis WHO meningitis antibiotics antimicrobial medicines bacteria bacterial infections central nervous system infections diabetes encephalitis meningitis meningitis/encephalitis mortality patient care management viral infections viruses

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
05 2019
Historique:
entrez: 20 4 2019
pubmed: 20 4 2019
medline: 13 11 2019
Statut: ppublish

Résumé

During 2003-2011, we recruited 1,065 patients of all ages admitted to Mahosot Hospital (Vientiane, Laos) with suspected central nervous system (CNS) infection. Etiologies were laboratory confirmed for 42.3% of patients, who mostly had infections with emerging pathogens: viruses in 16.2% (mainly Japanese encephalitis virus [8.8%]); bacteria in 16.4% (including Orientia tsutsugamushi [2.9%], Leptospira spp. [2.3%], and Rickettsia spp. [2.3%]); and Cryptococcus spp. fungi in 6.6%. We observed no significant differences in distribution of clinical encephalitis and meningitis by bacterial or viral etiology. However, patients with bacterial CNS infection were more likely to have a history of diabetes than others. Death (26.3%) was associated with low Glasgow Coma Scale score, and the mortality rate was higher for patients with bacterial than viral infections. No clinical or laboratory variables could guide antibiotic selection. We conclude that high-dependency units and first-line treatment with ceftriaxone and doxycycline for suspected CNS infections could improve patient survival in Laos.

Identifiants

pubmed: 31002063
doi: 10.3201/eid2505.180914
pmc: PMC6478220
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

898-910

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Références

J Clin Microbiol. 2001 Apr;39(4):1553-8
pubmed: 11283086
Lancet Glob Health. 2015 Feb;3(2):e104-12
pubmed: 25617190
Neurol Int. 2012 Oct 5;4(3):e15
pubmed: 23355928
Hawaii J Med Public Health. 2013 Jun;72(6 Suppl 2):28-32
pubmed: 23901379
Lancet. 2000 Mar 25;355(9209):1053-9
pubmed: 10744091
Am J Trop Med Hyg. 2009 May;80(5):837-40
pubmed: 19407134
J Clin Microbiol. 2007 Aug;45(8):2460-6
pubmed: 17537936
Emerg Infect Dis. 2015 Feb;21(2):280-9
pubmed: 25627940
J Clin Microbiol. 2000 Jul;38(7):2638-42
pubmed: 10878056
J Virol Methods. 2006 Mar;132(1-2):166-73
pubmed: 16274752
Lancet Infect Dis. 2015 Dec;15(12):1376-7
pubmed: 26607119
Diagn Microbiol Infect Dis. 2002 Feb;42(2):99-105
pubmed: 11858904
PLoS One. 2012;7(8):e42099
pubmed: 22952590
PLoS One. 2011 Jan 24;6(1):e16236
pubmed: 21283633
J Neurol. 2015;262(4):890-8
pubmed: 25634680
Vaccine. 2011 Jan 10;29(3):599-612
pubmed: 20600491
Intern Med J. 2016 Feb;46(2):148-57
pubmed: 26899887
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
Mol Cell Probes. 2007 Feb;21(1):17-23
pubmed: 16893625
PLoS One. 2012;7(5):e37825
pubmed: 22662232
J Clin Virol. 2009 May;45(1):61-6
pubmed: 19345140
Appl Microbiol. 1973 Jun;25(6):976-80
pubmed: 4736794
Clin Infect Dis. 2006 Dec 15;43(12):1565-77
pubmed: 17109290
J Clin Microbiol. 2001 Dec;39(12):4362-9
pubmed: 11724846
Clin Infect Dis. 2003 Mar 15;36(6):731-42
pubmed: 12627357
Am J Trop Med Hyg. 2001 Dec;65(6):848-51
pubmed: 11791985
PLoS Negl Trop Dis. 2013 Aug 29;7(8):e2163
pubmed: 24009783
PLoS One. 2012;7(2):e32486
pubmed: 22389704
Am J Trop Med Hyg. 2015 Aug;93(2):232-237
pubmed: 26055741
Vector Borne Zoonotic Dis. 2007 Winter;7(4):467-77
pubmed: 18020965
J Clin Microbiol. 2000 Nov;38(11):4066-71
pubmed: 11060069
BMC Anesthesiol. 2016 Jan 22;16:8
pubmed: 26801983
Clin Infect Dis. 2008 Mar 1;46(5):659-67
pubmed: 19413493
Vector Borne Zoonotic Dis. 2010 Mar;10(2):195-7
pubmed: 19492949
PLoS One. 2015 Dec 03;10(12):e0144366
pubmed: 26633824
BMC Infect Dis. 2009 May 08;9:57
pubmed: 19426501
J Med Virol. 2005 Mar;75(3):470-4
pubmed: 15648065
Am J Trop Med Hyg. 2012 Jul;87(1):171-178
pubmed: 22764310
Am J Trop Med Hyg. 2004 Apr;70(4):351-6
pubmed: 15100446
Am J Trop Med Hyg. 2010 Sep;83(3):451-7
pubmed: 20810803
PLoS Negl Trop Dis. 2014 Jan 30;8(1):e2533
pubmed: 24498443
J Pediatric Infect Dis Soc. 2013 Sep;2(3):267-9
pubmed: 26619481
Vector Borne Zoonotic Dis. 2012 Mar;12(3):175-82
pubmed: 22022815
J Clin Microbiol. 2001 Jan;39(1):196-200
pubmed: 11136770
Trop Med Int Health. 2009 Nov;14(11):1365-73
pubmed: 19747185
Acta Paediatr Jpn. 1992 Jun;34(3):350-7
pubmed: 1509881

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH